Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05208905 · ClinicalTrials.gov registry record · NA
LIFE-BTK PK Sub-study
A NA study of Critical Limb Ischemia (CLI), sponsored by Abbott Medical Devices.
- Active
- Registry status
- NA
- Development phase
- 9
- Enrollment target
- 5
- Study locations
NCT05208905 is a NA study of Critical Limb Ischemia (CLI) that is active but no longer recruiting, run by Abbott Medical Devices. The registered enrollment target is 9 participants. The trial reports 5 study locations across 5 states.
The verdict
NCT05208905, a NA study of Critical Limb Ischemia (CLI), is active but no longer recruiting, sponsored by Abbott Medical Devices.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 9 participants
- Enrollment target
- 5
- Study locations
Study Summary
LIFE-BTK PK is a prospective, single-arm, open-label, non-blinded, non-randomized sub-study of LIFE-BTK Randomized Controlled Trial (NCT04227899), that will enroll approximately 7 subjects in the United States (US) and outside the US with a maximum of 5 sites in the US. Of the 7 subjects planned to be enrolled, 4 subjects will be treated with Esprit BTK in below the knee artery(ies) in whom drug-coated balloons (DCB) were not used; 3 subjects will be treated with Esprit BTK in below the knee artery(ies) in whom DCB were used for treatment of inflow disease.
Conditions Studied
Interventions
- DEVICE Esprit BTK Device
Study Locations (5)
Florida
- First Coast Cardiovascular Institute - Jacksonville
Massachusetts
- Charlton Memorial Hospital - South Dartmouth
Oklahoma
- Ascension St. John Jane Phillips - Bartlesville
WAUS
- Sir Charles Gairdner Hospital - Nedlands
Other
- National Taiwan University Hospital - Taipei
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 2022-02-10 |
| Est. Completion | 2028-02-22 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05208905
The ClinicalTrials.gov registry entry for NCT05208905 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 9 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Abbott Medical Devices, which has 261 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Critical Limb Ischemia (CLI) appearing as the primary indexed condition, and to 1 intervention - of which Esprit BTK Device is the first listed.
NCT05208905 reports 5 study locations spanning 5 distinct geographic areas - top geographies include Florida, Massachusetts, Oklahoma.
Frequently Asked Questions
What is clinical trial NCT05208905 about?
NCT05208905 is a clinical study titled "LIFE-BTK PK Sub-study". LIFE-BTK PK is a prospective, single-arm, open-label, non-blinded, non-randomized sub-study of LIFE-BTK Randomized Controlled Trial (NCT04227899), that will enroll approximately 7 subjects in the United States (US) and outside the US with a maximum of 5 sites in the US. Of the 7 subjects planned to ...
What is the current status of trial NCT05208905?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 9 participants. The study started on 2022-02-10. Estimated completion is 2028-02-22.
What conditions does trial NCT05208905 study?
This clinical trial studies the following conditions: Critical Limb Ischemia (CLI).
What interventions are being tested in trial NCT05208905?
The interventions under investigation include: Esprit BTK Device (DEVICE).
Who is sponsoring clinical trial NCT05208905?
This trial is sponsored by Abbott Medical Devices, which has 261 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05208905 being conducted?
This trial has 5 study locations across Florida, Massachusetts, Oklahoma, WAUS. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Critical Limb Ischemia (CLI)
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.